Confidently Navigate Evolving Global Regulatory Policies, Robustly Drive Data Collection to Support Drug Development & Overcome the Operational Hurdles of Expanded Access Programs to Bring Life Saving Treatments to Patients More Efficiently

We are in an era of greater patient engagement awareness of access programs and trial technological advancements. To truly ensure expanded/managed access programs are operationalized, discussions around navigating global regulations, organizing logical supply and ethical considerations are needed.

Join the Operationalize: Expanded Access Programs Summit to discover practical applications for expanded access programs, through real-world case studies for setting-up, running and closing both local and global programs for a variety of disease areas. Come away with a better understating of how to achieve the of ultimate goal, bring better drugs to patients faster.

Our World-Class Speaker Faculty Includes:

Annie Drelles

Director & Head of Office of Medical Access, Global Oncology & Medical Affairs

Daiichi Sankyo

Mario Aguiar

Director - Global Medical Affairs & Rare Diseases

Sanofi Genzyme

Rachel Harrison

Associate Director - Early Access Program

Apellis Pharmaceuticals

Annmarie Galli

Head of Global Medical Affairs Research, Compassionate Use & Managed Access Programs Oncology

GlaxoSmithKline

Michelle Clausen

Senior Director - Expanded Access & Enterprise Medical Community

Pfizer

Testimonial

Our Partners